Depression among outpatients with diabetic peripheral neuropathy: prevalence and associated factors. [PDF]
Gharaibeh B+3 more
europepmc +1 more source
Therapeutic plasma exchange safely reduces biological age by up to 2.6 years. Multi‐omics analysis reveals coordinated cellular and molecular responses associated with aging rejuvenation. ABSTRACT We conducted a randomized, placebo‐controlled trial to assess the safety and biological age (BA) effects of various therapeutic plasma exchange (TPE ...
Matias Fuentealba+14 more
wiley +1 more source
Electrotherapy as treatment for chemotherapy-induced peripheral neuropathy - a randomized controlled trial. [PDF]
Sassmann R+11 more
europepmc +1 more source
Rare but relevant: Nitrous oxide and peripheral neurotoxicity, what do we know?
Abstract Nitrous oxide (N2O), used medically as an anaesthetic, has gained popularity as a recreational drug, with rising prevalence particularly among young adults. While its reinforcing and addictive potential remains debated, N2O is proven to be neurotoxic, especially with prolonged, heavy use, which is often unexpected for users.
Tibor M. Brunt+2 more
wiley +1 more source
Prevalence, patterns and determinants of peripheral neuropathy among leprosy patients in Northeast Ethiopia: A retrospective study. [PDF]
Muhaba ES+3 more
europepmc +1 more source
Mutations in the peripheral myelin genes and associated genes in inherited peripheral neuropathies
Eva Nelis+2 more
openalex +1 more source
Abstract Introduction An ethics‐guided decision‐making framework was developed for applying pathology‐supported genetic testing, a multifaceted pharmacodiagnostic approach that translates population risk stratification into clinical utility. We introduce this service, supported by the Open Genome Project, which aligns with the beneficence principle in ...
Manie De Klerk+6 more
wiley +1 more source
Proteomic and Metabolomic Analysis of the Neuroprotective Effects of <i>Lycium Ruthenicum</i> Polyphenols in Diabetic Peripheral Neuropathy Mice. [PDF]
Tian Q, Cao H, Chu L, Gao H, Gao Q.
europepmc +1 more source
The study aimed to determine the optimal timing and duration of filgrastim administration for the primary prevention of febrile neutropenia (FN) in breast cancer patients undergoing adjuvant TAC chemotherapy. Our findings suggest that initiating daily filgrastim from Day 2 and continuing for 7 days optimizes toxicity reduction.
Zisun Kim+7 more
wiley +1 more source
Perineural Electrical Dry Needling and Neural Mobilization for Chemotherapy-Induced Peripheral Neuropathy: Case Report. [PDF]
Granger A, Dunning J, Young I.
europepmc +1 more source